Govt Places Order For 66 Crore COVID-19 Vaccine Doses From Serum Institute, Bharat BiotechCovaxin and Covishield

Amid the ongoing Covid-19 vaccination drive, the Union government has placed an order for 66 crore doses of Serum Institute of India's (SII) Covishield and Bharat Biotech's Covaxin.

The order has been placed for supply of 66 crore Covid-19 vaccine doses at a cost of Rs 14,505.75 crore between August and December.

Further, 22 crore Covid-19 vaccine doses will be made available to the private sector.

Over the next five months, the government aims to get 37.5 crore doses of Covishield and 28.5 crore of Bharat Biotech's Covaxin, reports Economic Times.

The fresh order has been placed at Rs 215.25 per dose for Covishield and Rs 225.75 per dose for Covaxin, inclusive of GST.

The development comes as Centre, in an affidavit filed on 25 June, told the Supreme Court that India will have access to 1.35 Covid-19 vaccine doses through December, enough to cover the eligible adult population of the country.

The government's estimate includes 50 crore doses of Covishield, 40 crore of Covaxin, 30 crore of Biological E's vaccine, 5 crore of Zydus' jab and 10 crore Russian Sputnik V jabs.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber